Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.

Adelaide de Mauleon, Sandrine Sourdet, Anna Renom-Guiteras, Sophie Gillette-Guyonnet, Helena Leino-Kilpi, Staffan Karlsson, Michel Bleijlevens, Adela Zabategui, Kai Saks, Bruno Vellas, David Jolley, Maria Soto

    Research output: Contribution to journalArticlepeer-review

    29 Citations (SciVal)

    Abstract

    To determine factors associated with the antipsychotic (AP) prescription for people with dementia (PwD) recently admitted to institutional long-term care facilities (LTCFs) and to ascertain differences in the use of this medication in 8 European countries.
    Original languageEnglish
    Pages (from-to)812-818
    JournalJournal of the American Medical Directors Association
    Volume15
    Issue number11
    DOIs
    Publication statusPublished - 2014

    Subject classification (UKÄ)

    • Health Care Service and Management, Health Policy and Services and Health Economy

    Fingerprint

    Dive into the research topics of 'Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.'. Together they form a unique fingerprint.

    Cite this